CEREBRAL LESIONS IN PRETERM INFANTS AFTER TOCOLYTIC INDOMETHACIN
| Autor: | W. Baerts, W. P. F. Fetter, H. C. S. Wallenburg, Wim C. J. Hop, R. Spritzer, Pjj Sauer |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
congenital hereditary and neonatal diseases and abnormalities Tocolytic agent Pediatrics medicine.medical_specialty Leukomalacia Periventricular Indomethacin Tocolysis Infant Premature Diseases Obstetric Labor Premature Developmental Neuroscience Administration Rectal Pregnancy Risk Factors Ductus arteriosus medicine Fetal distress Humans Rupture of membranes Hypoxia Brain Ductus Arteriosus Patent Cerebral Hemorrhage Periventricular leukomalacia Dose-Response Relationship Drug business.industry Obstetrics Infant Newborn Brain medicine.disease Echoencephalography medicine.anatomical_structure Tocolytic Pediatrics Perinatology and Child Health Gestation Brain Damage Chronic Female Neurology (clinical) business |
| Zdroj: | Developmental Medicine & Child Neurology. 32:910-918 |
| ISSN: | 1469-8749 0012-1622 |
| DOI: | 10.1111/j.1469-8749.1990.tb08104.x |
| Popis: | The incidence and type of cerebral lesions in 159 infants born before 30 weeks gestation were studied, using ultrasound. Indomethacin was given as part of tocolytic management to mothers with a high incidence of early rupture of membranes and preterm labour; and 76 fetuses were exposed to the drug as a result. For the remaining 83 pregnancies, in which there was a high incidence of chronic fetal distress and in utero hypoxia, tocolysis was either not started or limited to fenoterol. The neonatal course was similar for both groups of infants, except that patent ductus arteriosus was less commonly diagnosed in the 76 infants exposed to indomethacin. However, the incidence of periventricular leukomalacia was increased among infants exposed to any tocolytic agent; and cystic lesions occurred more commonly in those exposed to indomethacin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text